APP-FUBINACA

APP-FUBINACA is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the CB1 receptor, with a Ki of 708 nM, while its EC50 was not tested. It contains a phenylalanine amino acid residue in its structure.

Legality
Sweden's public health agency suggested to classify APP-FUBINACA as hazardous substance on March 24, 2015.